These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24288134)

  • 1. Dopamine and Cu+/2+ can induce oligomerization of α-synuclein in the absence of oxygen: Two types of oligomerization mechanisms for α-synuclein and related cell toxicity studies.
    Ha Y; Yang A; Lee S; Kim K; Liew H; Lee SH; Lee JE; Lee HI; Suh YH; Park HS; Churchill DG
    J Neurosci Res; 2014 Mar; 92(3):359-68. PubMed ID: 24288134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways.
    Anandhan A; Rodriguez-Rocha H; Bohovych I; Griggs AM; Zavala-Flores L; Reyes-Reyes EM; Seravalli J; Stanciu LA; Lee J; Rochet JC; Khalimonchuk O; Franco R
    Neurobiol Dis; 2015 Sep; 81():76-92. PubMed ID: 25497688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facile "stop codon" method reveals elevated neuronal toxicity by discrete S87p-α-synuclein oligomers.
    Ha Y; Yang A; Lee S; Kim K; Liew H; Suh YH; Park HS; Churchill DG
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1085-91. PubMed ID: 24380864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity.
    Xiang W; Schlachetzki JC; Helling S; Bussmann JC; Berlinghof M; Schäffer TE; Marcus K; Winkler J; Klucken J; Becker CM
    Mol Cell Neurosci; 2013 May; 54():71-83. PubMed ID: 23369945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner.
    Pham CL; Leong SL; Ali FE; Kenche VB; Hill AF; Gras SL; Barnham KJ; Cappai R
    J Mol Biol; 2009 Apr; 387(3):771-85. PubMed ID: 19361420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid interaction of alpha-synuclein during the metal-catalyzed oxidation in the presence of Cu2+ and H2O2.
    Lee EN; Lee SY; Lee D; Kim J; Paik SR
    J Neurochem; 2003 Mar; 84(5):1128-42. PubMed ID: 12603836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox activity of α-synuclein-Cu is silenced by Zn₇-metallothionein-3.
    Meloni G; Vašák M
    Free Radic Biol Med; 2011 Jun; 50(11):1471-9. PubMed ID: 21320589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein.
    Jinsmaa Y; Sullivan P; Gross D; Cooney A; Sharabi Y; Goldstein DS
    Neurosci Lett; 2014 May; 569():27-32. PubMed ID: 24670480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells.
    Yamakawa K; Izumi Y; Takeuchi H; Yamamoto N; Kume T; Akaike A; Takahashi R; Shimohama S; Sawada H
    Biochem Biophys Res Commun; 2010 Jan; 391(1):129-34. PubMed ID: 19900407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation.
    Leong SL; Pham CL; Galatis D; Fodero-Tavoletti MT; Perez K; Hill AF; Masters CL; Ali FE; Barnham KJ; Cappai R
    Free Radic Biol Med; 2009 May; 46(10):1328-37. PubMed ID: 19248830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
    Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T
    Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper(II)-induced self-oligomerization of alpha-synuclein.
    Paik SR; Shin HJ; Lee JH; Chang CS; Kim J
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):821-8. PubMed ID: 10359669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early events in copper-ion catalyzed oxidation of α-synuclein.
    Tiwari MK; Leinisch F; Sahin C; Møller IM; Otzen DE; Davies MJ; Bjerrum MJ
    Free Radic Biol Med; 2018 Jun; 121():38-50. PubMed ID: 29689296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.
    Paik SR; Shin HJ; Lee JH
    Arch Biochem Biophys; 2000 Jun; 378(2):269-77. PubMed ID: 10860544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.
    Moussa CE; Wersinger C; Tomita Y; Sidhu A
    Biochemistry; 2004 May; 43(18):5539-50. PubMed ID: 15122920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp27 suppresses the Cu(2+)-induced amyloidogenicity, redox activity, and cytotoxicity of α-synuclein by metal ion stripping.
    Asthana A; Bollapalli M; Tangirala R; Bakthisaran R; Mohan Rao Ch
    Free Radic Biol Med; 2014 Jul; 72():176-90. PubMed ID: 24746619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual effects of alpha-synuclein on neurotoxicity induced by low dosage of rotenone are dependent on exposure time in dopaminergic neuroblastoma cells.
    Lu L; Gu L; Liang Y; Sun X; Duan C; Yang H
    Sci China Life Sci; 2010 May; 53(5):590-7. PubMed ID: 20596942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of human α-synuclein aggregation by a combined effect of calcium and dopamine.
    Jain MK; Bhat R
    Neurobiol Dis; 2014 Mar; 63():115-28. PubMed ID: 24269918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review on the interactions between dopamine metabolites and α-Synuclein in causing Parkinson's disease.
    Sivakumar P; Nagashanmugam KB; Priyatharshni S; Lavanya R; Prabhu N; Ponnusamy S
    Neurochem Int; 2023 Jan; 162():105461. PubMed ID: 36460239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of alpha-synuclein fibrillization by dopamine analogs via reaction with the amino groups of alpha-synuclein. Implication for dopaminergic neurodegeneration.
    Li HT; Lin DH; Luo XY; Zhang F; Ji LN; Du HN; Song GQ; Hu J; Zhou JW; Hu HY
    FEBS J; 2005 Jul; 272(14):3661-72. PubMed ID: 16008565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.